Scribd
Upload
6 views2 pages

Mod 3

The document highlights significant barriers faced by marginalized women in France regarding participation in clinical research, including complex consent processes, trust issues, and lack of accessible information. It notes that 30% of marginalized women found consent procedures difficult, while 45% expressed distrust towards medical institutions. To improve participation, the document suggests implementing targeted outreach programs, logistical support, and simplifying consent processes.

Uploaded by

tanirikabansal
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
6 views2 pages

Mod 3

The document highlights significant barriers faced by marginalized women in France regarding participation in clinical research, including complex consent processes, trust issues, and lack of accessible information. It notes that 30% of marginalized women found consent procedures difficult, while 45% expressed distrust towards medical institutions. To improve participation, the document suggests implementing targeted outreach programs, logistical support, and simplifying consent processes.

Uploaded by

tanirikabansal
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 2

while common barriers like information gaps and socioeconomic challenges are noted in countries

like the UK , France would like to point out some barriers which requires our unvavering attention
For instance, 30% of marginalized women reported that complex consent processes detterered their
participation, a barrier less frequently mentioned elsewhere.

the consent forms or procedures were difficult to understand or navigate, which discouraged these
women from participating in the research studies. This barrier may arise due to legal or ethical
requirements, language barriers, or the complexity of the information provided to participants.
Simplifying the consent processes can help alleviate this barrier and encourage more women to
participate in clinical research.

Trust issues remain pervasive. Historical mistreatment in medical research has left deep scars. In a
2020 survey, 45% of marginalized women expressed distrust towards medical institutions, fearing
exploitation and discrimination.

A major barrier is the lack of accessible information. A 2019 survey indicated that 40% of
marginalized women in France were unaware of clinical research opportunities

Today, we confront the urgent issue of barriers to participation of marginalized women in clinical
research in France. Despite our progress, significant obstacles persist for these women, particularly
from ethnic minorities and low-income backgrounds.

Consider this: a 2021 study revealed that only 15% of clinical trial participants in France are from
ethnic minority groups, although these groups comprise nearly 25% of our population. This stark
disparity highlights systemic barriers needing immediate attention.

. Linguistic challenges compound this issue, as over 30% of these women speak French as a second
language, complicating their understanding of medical terminology.

Socioeconomic factors are also significant. About 35% of women from low-income backgrounds
reported that transportation costs prevented their participation in clinical trials. Furthermore, 25%
cited childcare responsibilities as a barrier, highlighting the need for supportive services.
To overcome these barriers, France must implement targeted outreach programs, provide logistical
support, and simplify consent processes. By addressing these unique challenges, we can ensure that
clinical research becomes more inclusive and representative of our diverse population.

Thank you.

You might also like